Our results revealed highly significant differences in the expression levels of miR-29a, miR-106a, and miR-200a in GBM patients compared to healthy volunteers, indicating that the identified miRs could be potential molecular markers for GBM diagnosis and prediction.
← all excerpts
Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.
1
—
—